Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib. (Q51474966)
Jump to navigation
Jump to search
scientific article published on 26 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib. |
scientific article published on 26 March 2007 |
Statements
Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib. (English)
1 reference
Breccia M
1 reference
Muscaritoli M
1 reference
Gentilini F
1 reference
Latagliata R
1 reference
Carmosino I
1 reference
Alimena G
1 reference
26 March 2007
1 reference
31
1 reference
12
1 reference
1770-1772
1 reference